Veradermics Reports Positive Phase 2 Results for Oral Hair Loss Drug
Veradermics announced positive Phase 2 study results for VDPHL01 in female hair loss. The data positions the drug as a potential first FDA-approved oral treatment for this indication.
View filing at SEC.gov →